TherapyEdge, ABL and MSH Enter into Agreement to Collaborate on Integration of Software for the Management of HIV, Tuberculosis

Share Article

TherapyEdge, Inc., ABL, S.A., and MSH, Inc. (MSH) today announced the completion of an agreement to develop an interface between ABL's proprietary TherapyEdge and MSH's proprietary RxSolution for the Management of HIV and Tuberculosis. Development of an interface between the two software products will allow for a fully integrated IT solution for clinical services and medicines supply management.

Working with MSH to develop the interface between TherapyEdge and RxSolution will be an important milestone for ABL's powerful technology

TherapyEdge, Inc., and Advanced Biological Laboratories (ABL), S.A., and Management Sciences for Health, Inc. (MSH) today announced the completion of an agreement to develop an interface between ABL's proprietary TherapyEdge and MSH's proprietary RxSolution. Development of an interface between the two software products will allow for a fully integrated IT solution for clinical services and medicines supply management. The interface will also enable the issuance of fully automated global reporting, consistent with existing and future requirements from various stakeholders such as the World Health Organization, (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the United States Agency for International Development (USAID), Clinton Foundation, and the Bill and Melinda Gates Foundation.

In many countries, particularly those that are underdeveloped and resource limited, incongruent delivery of care and management of the supply of medicines and other health care commodities are challenges in the fight against HIV, tuberculosis, and other medical conditions. For example, when hospital stocks of medicines for the treatment of HIV or TB infections run behind demand, patient therapy will be interrupted and the risk of the development of drug-resistant TB or HIV dramatically increases.

Integration of IT pharmaceutical management systems, like RxSolution, and patient management systems, like TherapyEdge, is essential for the successful delivery of the comprehensive package of care and optimal healthcare management programs.

TherapyEdge is a comprehensive patient record hospital information system to be used for data management, monitoring and reporting applications. It is already communicating with expert systems for HIV or TB disease management, allowing personalized therapy selection and optimal diagnostic monitoring and evaluation. Through HL7, TherapyEdge has already interfaced with global hospital information systems (HIS) in Europe and Asia and soon in Africa. It can also be combined with the ViroScore Suite sequence database and resistance (HIV and TB) interpretation system to create a powerful clinical patient management system and research tool. It is used in over 75 clinical sites in 35 countries by NGO's, as their primary longitudinal patient record, by government organizations to track program indicators and expenditures, by researchers to learn more about the resistance profiles and by virologists and clinicians to improve the quality of care.

RxSolution is an integrated computerized pharmaceutical management system developed by MSH. This system, which was funded by the United States Agency for International Development (USAID), is used to manage inventory; process purchase orders; handle issues to wards, out/in-patient pharmacy, and satellite clinics; dispense medication to patients; and prepare repeat scripts for down-referral at the facility level (hospital, community health center, primary health care clinic, and district office). RxSolution supports best practices for procurement, storage, distribution, and dispensing of pharmaceuticals and medical supplies, helping to ensure availability of critical products at all times. The software is currently widely used in South Africa, Lesotho, and Swaziland with a total of more than 100 installations.

"Working with MSH to develop the interface between TherapyEdge and RxSolution will be an important milestone for ABL's powerful technology," said Ronan Boulmé, Vice President of Research and Development at TherapyEdge and ABL. "RxSolution is one of the premiere pharmacy management tools available and used, with comprehensive, user-friendly functionalities, which will complement TherapyEdge's patient care management system very well. At TherapyEdge and ABL, substantial efforts are devoted to interface TherapyEdge with strategic information systems from third parties to continue to improve healthcare and patient personalized medicine and care."

ABL and MSH expect to complete integration of the two software products which will allow exchange of data files from one program to the other without manual intervention by summer 2008.

About TherapyEdge, Inc. and ABL, S.A.: Advanced Biological Laboratories (ABL), S.A., is a biotech company founded in 2000 as a spin-off from the European academic research center, CRP-Santé, Luxembourg and in 2004, acquired the control of TherapyEdge, Inc. TherapyEdge is a biotech company founded in 2000 as a spin-off from Triangle Pharmaceuticals, Inc., which had been acquired by Gilead Sciences in December 2002. TherapyEdge and ABL's expertise lies within infectious diseases, with particular focus on resistance patterns and clinical outcome predictors for HIV-1, tuberculosis, hepatitis, malaria and human papillomavirus (HPV) infections. ABL was selected to supply the technology platform to support the SPREAD HIV resistance study in 16 countries, the EuropeHIVResistance (European Union-sponsored program) in 32 countries, and is actively participating in both private- and public-sector research. The ViroScore Suite and TherapyEdge systems are used worldwide to support optimal clinical care for individuals with complex diseases. TherapyEdge and ABL have offices in the USA, Luxembourg, and South Africa, and partners in Asia. For more information, please see http://www.therapyedge.com

About MSH: Management Sciences for Health, Inc. is a not-for-profit organization that works collaboratively with health care policymakers, managers, providers, and clients worldwide to improve the delivery of health services through the application of practical management tools. MSH has over 30 years of experience providing training and technical assistance in pharmaceuticals management and other health areas in over 100 countries. For more information, please see http://www.msh.org

Contact Information:
TherapyEdge, Inc.
Advanced Biological Laboratories, S.A.
Chalom Sayada, MD, PhD
President and Chief Executive Officer
Tel : +1 919 386 8041 or +352 2638 8921

Ron Snapper
Regional Manager
South Africa
Tel : + 27 74 102 8629

Management Sciences for Health
Jean-Pierre Sallet
Regional Technical Advisor
South Africa
Tel : +27 12 326 4027

Arin Speed
Electronic Tools Manager
United States
Tel : +1 703 524 6575

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dr Chalom Sayada
TherapyEdge Inc
+1 (919) 386-8041
Email >

Mr Arin Speed
Visit website